Home LiteratureArticle Details
PMID: 12525611 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1.

Journal of virology ·Vol. 77 ·No. 3 ·2003-02-00 ·Pages 1772-83

Liang C, Hu J, Whitney JB, Kleiman L, Wainberg MA

Abstract

Crystal structures of human immunodeficiency virus type 1 (HIV-1) capsid protein (CA) reveal that the last 11 C-terminal amino acids are disordered. This disordered region contains a glycine-rich sequence 353-GVGGP-357 (numbering refers to the initiation methionine of Gag) that is highly conserved within the Gag proteins of HIV-1, HIV-2, and simian immunodeficiency virus, which suggests the importance of this sequence in virus replication. In the present study, we demonstrate that changing any individual residue within this short region in the context of the full-length HIV-1 genome virtually abolishes production of extracellular virus particles, in either the presence or absence of viral protease activity. This severe defect in virus particle production results from impaired Gag multimerization, as well as from decreased Gag association with the cellular membranes, as demonstrated by the results of gradient sedimentation and membrane flotation centrifugation assays. These findings are further supported by the diffuse distribution pattern of the mutant Gag within the cytoplasm, as opposed to the punctate distribution of the wild-type Gag on the plasma membrane. On the basis of these results, we propose that the disordered feature of amino acid stretch 353-GVGGP-357 in the CA crystal forms may have allowed Gag to adopt multiple conformations and that such structural flexibility is needed by Gag in order to construct geometrically complex particles.

MeSH Terms
Animals COS Cells Capsid/chemistry,physiology Cytoplasm/chemistry Gene Products, gag/analysis,chemistry,metabolism HIV-1/physiology Virus Assembly Virus Replication
Chemicals
Gene Products, gag
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Liang Chen
McGill AIDS Centre, Lady Davis Institute-Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada. [email protected]
Hu Jing
Whitney James B
Kleiman Lawrence
Wainberg Mark A
References (67)
67 references, click to expand
  1. A multistep, ATP-dependent pathway for assembly of human immunodeficiency virus capsids in a cell-free system.
    J Cell Biol. 1997 Feb 10;136(3):567-81 PMID: 9024688
  2. Structure-based rationale for the rescue of systemic movement of brome mosaic virus by spontaneous second-site mutations in the coat protein gene.
    J Virol. 1997 Mar;71(3):2500-4 PMID: 9032390
  3. Quasi-equivalent viruses: a paradigm for protein assemblies.
    J Mol Biol. 1997 Jun 27;269(5):665-75 PMID: 9223631
  4. Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution.
    Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 PMID: 10089398
  5. Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication.
    J Hum Virol. 1998 Mar-Apr;1(3):240-7 PMID: 10195247
  6. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
    J Virol. 1999 May;73(5):4136-44 PMID: 10196310
  7. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
    J Virol. 1999 Oct;73(10):8527-40 PMID: 10482606
  8. Physical principles in the construction of regular viruses.
    Cold Spring Harb Symp Quant Biol. 1962;27:1-24 PMID: 14019094
  9. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).
    Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 PMID: 11427703
  10. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.
    Cell. 2001 Oct 5;107(1):55-65 PMID: 11595185
  11. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
    Nat Med. 2001 Dec;7(12):1313-9 PMID: 11726971
  12. Role of RNA in facilitating Gag/Gag-Pol interaction.
    J Virol. 2002 Apr;76(8):4131-7 PMID: 11907255
  13. Viral late domains.
    J Virol. 2002 May;76(10):4679-87 PMID: 11967285
  14. Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.
    J Virol. 1988 Nov;62(11):4393-7 PMID: 3050149
  15. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5 PMID: 2788277
  16. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.
    Cell. 1989 Oct 6;59(1):103-12 PMID: 2676191
  17. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
    AIDS Res Hum Retroviruses. 1989 Dec;5(6):577-91 PMID: 2692658
  18. Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions.
    J Med Primatol. 1990;19(3-4):411-9 PMID: 2231692
  19. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein.
    J Virol. 1991 Feb;65(2):922-30 PMID: 1987379
  20. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 PMID: 2014240
  21. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation.
    J Gen Virol. 1992 Dec;73 ( Pt 12):3079-86 PMID: 1469349
  22. Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation.
    Virology. 1993 Apr;193(2):981-5 PMID: 8460500
  23. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.
    J Virol. 1994 Apr;68(4):2556-69 PMID: 8139035
  24. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
    J Virol. 1994 May;68(5):3232-42 PMID: 8151785
  25. Assembly of HIV GAG-B-galactosidase fusion proteins into virus particles.
    Virology. 1994 May 1;200(2):524-34 PMID: 8178440
  26. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.
    Proc Natl Acad Sci U S A. 1994 May 10;91(10):4594-8 PMID: 8183954
  27. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.
    J Virol. 1994 Aug;68(8):4927-36 PMID: 8035491
  28. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
    J Virol. 1994 Dec;68(12):8017-27 PMID: 7966591
  29. Functional domains of the capsid protein of human immunodeficiency virus type 1.
    J Virol. 1994 Dec;68(12):8180-7 PMID: 7966609
  30. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
    J Virol. 1995 Feb;69(2):642-50 PMID: 7815527
  31. Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases.
    Eur J Biochem. 1995 Feb 15;228(1):191-8 PMID: 7883003
  32. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
    J Virol. 1995 Jun;69(6):3407-19 PMID: 7745687
  33. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.
    J Virol. 1995 Oct;69(10):6106-14 PMID: 7666514
  34. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
    J Virol. 1995 Oct;69(10):6487-97 PMID: 7666550
  35. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    J Virol. 1995 Nov;69(11):6810-8 PMID: 7474093
  36. Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly.
    J Gen Virol. 1996 Apr;77 ( Pt 4):743-51 PMID: 8627263
  37. Structure of the amino-terminal core domain of the HIV-1 capsid protein.
    Science. 1996 Jul 12;273(5272):231-5 PMID: 8662505
  38. Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.
    J Virol. 1996 Aug;70(8):5106-14 PMID: 8764018
  39. Crystal structure of dimeric HIV-1 capsid protein.
    Nat Struct Biol. 1996 Sep;3(9):763-70 PMID: 8784350
  40. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
    J Virol. 1997 Sep;71(9):6582-92 PMID: 9261380
  41. Inhibition of human immunodeficiency virus type 1 particle formation by alterations of defined amino acids within the C terminus of the capsid protein.
    J Gen Virol. 1997 Oct;78 ( Pt 10):2489-96 PMID: 9349469
  42. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.
    Science. 1997 Oct 31;278(5339):849-53 PMID: 9346481
  43. Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.
    J Virol. 2000 Jan;74(1):16-23 PMID: 10590086
  44. A conformational switch controlling HIV-1 morphogenesis.
    EMBO J. 2000 Jan 4;19(1):103-13 PMID: 10619849
  45. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
    J Virol. 2000 Apr;74(7):3046-57 PMID: 10708419
  46. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
    J Virol. 2000 Jun;74(11):5142-50 PMID: 10799589
  47. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    J Virol. 2000 Jun;74(12):5395-402 PMID: 10823843
  48. Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.
    J Virol. 2000 Jul;74(13):5845-55 PMID: 10846064
  49. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
    J Virol. 2000 Aug;74(16):7238-49 PMID: 10906178
  50. Image reconstructions of helical assemblies of the HIV-1 CA protein.
    Nature. 2000 Sep 21;407(6802):409-13 PMID: 11014200
  51. Role of the major homology region in assembly of HIV-1 Gag.
    Biochemistry. 2001 May 8;40(18):5565-72 PMID: 11331022
  52. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.
    Eur J Biochem. 1997 Oct 15;249(2):592-600 PMID: 9370371
  53. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
    J Virol. 1998 Mar;72(3):2072-8 PMID: 9499062
  54. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.
    J Virol. 1998 Apr;72(4):2723-32 PMID: 9525590
  55. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
    J Virol. 1998 Apr;72(4):2846-54 PMID: 9525604
  56. Identification and characterization of virus assembly intermediate complexes in HIV-1-infected CD4+ T cells.
    Virology. 1998 Mar 30;243(1):78-93 PMID: 9527917
  57. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.
    J Virol. 1998 Oct;72(10):7950-9 PMID: 9733833
  58. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.
    J Virol. 1998 Nov;72(11):9313-7 PMID: 9765481
  59. HIV-1 gag proteins: diverse functions in the virus life cycle.
    Virology. 1998 Nov 10;251(1):1-15 PMID: 9813197
  60. Assembly and analysis of conical models for the HIV-1 core.
    Science. 1999 Jan 1;283(5398):80-3 PMID: 9872746
  61. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.
    J Virol. 1999 Mar;73(3):1902-8 PMID: 9971769
  62. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
    J Virol. 1999 Mar;73(3):2270-9 PMID: 9971810
  63. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab.
    EMBO J. 1999 Mar 1;18(5):1124-36 PMID: 10064580
  64. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
    J Virol. 1999 Apr;73(4):2604-12 PMID: 10074105
  65. Dynamic interactions of the Gag polyprotein.
    Curr Top Microbiol Immunol. 1996;214:65-94 PMID: 8791725
  66. The major homology region of the HIV-1 gag precursor influences membrane affinity.
    Biochemistry. 1996 Nov 12;35(45):14268-75 PMID: 8916912
  67. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
    J Virol. 1996 Dec;70(12):8540-8 PMID: 8970978
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-02-00
Pages
1772-83
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC140948
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]